nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoclopramide—CHRM1—Carbachol—glaucoma	0.197	0.316	CbGbCtD
Metoclopramide—CHRM1—Pilocarpine—glaucoma	0.183	0.294	CbGbCtD
Metoclopramide—CYP2D6—Carteolol—glaucoma	0.0812	0.13	CbGbCtD
Metoclopramide—CYP2D6—Betaxolol—glaucoma	0.0548	0.088	CbGbCtD
Metoclopramide—CYP2D6—Methazolamide—glaucoma	0.0415	0.0667	CbGbCtD
Metoclopramide—CYP2D6—Timolol—glaucoma	0.0353	0.0567	CbGbCtD
Metoclopramide—CYP2D6—Clonidine—glaucoma	0.03	0.0482	CbGbCtD
Metoclopramide—Sunitinib—MYLK—glaucoma	0.00389	0.417	CrCbGaD
Metoclopramide—Sunitinib—TBK1—glaucoma	0.00389	0.417	CrCbGaD
Metoclopramide—Sunitinib—NTRK1—glaucoma	0.00155	0.166	CrCbGaD
Metoclopramide—Bronchospasm—Betaxolol—glaucoma	0.000528	0.00184	CcSEcCtD
Metoclopramide—Palpitations—Brimonidine—glaucoma	0.000527	0.00183	CcSEcCtD
Metoclopramide—Dizziness—Diclofenamide—glaucoma	0.000526	0.00183	CcSEcCtD
Metoclopramide—Asthenia—Methazolamide—glaucoma	0.000525	0.00183	CcSEcCtD
Metoclopramide—Tremor—Brinzolamide—glaucoma	0.000524	0.00182	CcSEcCtD
Metoclopramide—Diarrhoea—Levobunolol—glaucoma	0.000523	0.00182	CcSEcCtD
Metoclopramide—Nervousness—Pilocarpine—glaucoma	0.000522	0.00182	CcSEcCtD
Metoclopramide—Angioedema—Dorzolamide—glaucoma	0.00052	0.00181	CcSEcCtD
Metoclopramide—Nausea—Metipranolol—glaucoma	0.000519	0.0018	CcSEcCtD
Metoclopramide—Muscle spasms—Pilocarpine—glaucoma	0.000517	0.0018	CcSEcCtD
Metoclopramide—Hypertension—Brimonidine—glaucoma	0.000515	0.00179	CcSEcCtD
Metoclopramide—Agitation—Brinzolamide—glaucoma	0.000514	0.00179	CcSEcCtD
Metoclopramide—Dizziness—Carbachol—glaucoma	0.000513	0.00178	CcSEcCtD
Metoclopramide—Insomnia—Apraclonidine—glaucoma	0.000512	0.00178	CcSEcCtD
Metoclopramide—Confusional state—Acetazolamide—glaucoma	0.000511	0.00178	CcSEcCtD
Metoclopramide—Headache—Carteolol—glaucoma	0.000507	0.00176	CcSEcCtD
Metoclopramide—Anxiety—Brimonidine—glaucoma	0.000506	0.00176	CcSEcCtD
Metoclopramide—Dizziness—Levobunolol—glaucoma	0.000505	0.00176	CcSEcCtD
Metoclopramide—Dyspnoea—Apraclonidine—glaucoma	0.000505	0.00176	CcSEcCtD
Metoclopramide—Tremor—Pilocarpine—glaucoma	0.000504	0.00175	CcSEcCtD
Metoclopramide—Somnolence—Apraclonidine—glaucoma	0.000504	0.00175	CcSEcCtD
Metoclopramide—Palpitations—Dorzolamide—glaucoma	0.000503	0.00175	CcSEcCtD
Metoclopramide—Bradycardia—Clonidine—glaucoma	0.000502	0.00175	CcSEcCtD
Metoclopramide—Rash—Diclofenamide—glaucoma	0.000501	0.00174	CcSEcCtD
Metoclopramide—Diarrhoea—Methazolamide—glaucoma	0.000501	0.00174	CcSEcCtD
Metoclopramide—Palpitations—Travoprost—glaucoma	0.000501	0.00174	CcSEcCtD
Metoclopramide—Headache—Diclofenamide—glaucoma	0.000498	0.00173	CcSEcCtD
Metoclopramide—Insomnia—Bimatoprost—glaucoma	0.000497	0.00173	CcSEcCtD
Metoclopramide—Palpitations—Brinzolamide—glaucoma	0.000494	0.00172	CcSEcCtD
Metoclopramide—Erectile dysfunction—Betaxolol—glaucoma	0.000494	0.00172	CcSEcCtD
Metoclopramide—Agitation—Pilocarpine—glaucoma	0.000494	0.00172	CcSEcCtD
Metoclopramide—Hypertension—Dorzolamide—glaucoma	0.000491	0.00171	CcSEcCtD
Metoclopramide—Hallucination—Clonidine—glaucoma	0.000491	0.00171	CcSEcCtD
Metoclopramide—Dyspnoea—Bimatoprost—glaucoma	0.00049	0.0017	CcSEcCtD
Metoclopramide—Rash—Carbachol—glaucoma	0.000489	0.0017	CcSEcCtD
Metoclopramide—Hypertension—Travoprost—glaucoma	0.000489	0.0017	CcSEcCtD
Metoclopramide—Dermatitis—Carbachol—glaucoma	0.000489	0.0017	CcSEcCtD
Metoclopramide—Fatigue—Apraclonidine—glaucoma	0.000488	0.0017	CcSEcCtD
Metoclopramide—Somnolence—Bimatoprost—glaucoma	0.000488	0.0017	CcSEcCtD
Metoclopramide—Oedema—Brimonidine—glaucoma	0.000486	0.00169	CcSEcCtD
Metoclopramide—Headache—Carbachol—glaucoma	0.000486	0.00169	CcSEcCtD
Metoclopramide—Hypertension—Brinzolamide—glaucoma	0.000483	0.00168	CcSEcCtD
Metoclopramide—Anxiety—Dorzolamide—glaucoma	0.000483	0.00168	CcSEcCtD
Metoclopramide—Cardiac arrest—Timolol—glaucoma	0.000482	0.00168	CcSEcCtD
Metoclopramide—Leukopenia—Pilocarpine—glaucoma	0.000481	0.00167	CcSEcCtD
Metoclopramide—Anxiety—Travoprost—glaucoma	0.000481	0.00167	CcSEcCtD
Metoclopramide—Nausea—Carteolol—glaucoma	0.00048	0.00167	CcSEcCtD
Metoclopramide—Headache—Levobunolol—glaucoma	0.000479	0.00166	CcSEcCtD
Metoclopramide—Depression—Betaxolol—glaucoma	0.000477	0.00166	CcSEcCtD
Metoclopramide—Palpitations—Pilocarpine—glaucoma	0.000475	0.00165	CcSEcCtD
Metoclopramide—Tachycardia—Brimonidine—glaucoma	0.000475	0.00165	CcSEcCtD
Metoclopramide—Nausea—Diclofenamide—glaucoma	0.000472	0.00164	CcSEcCtD
Metoclopramide—Dizziness—Latanoprost—glaucoma	0.000469	0.00163	CcSEcCtD
Metoclopramide—Confusional state—Dorzolamide—glaucoma	0.000468	0.00163	CcSEcCtD
Metoclopramide—Feeling abnormal—Apraclonidine—glaucoma	0.000467	0.00162	CcSEcCtD
Metoclopramide—Oedema—Dorzolamide—glaucoma	0.000465	0.00162	CcSEcCtD
Metoclopramide—Hypertension—Pilocarpine—glaucoma	0.000464	0.00161	CcSEcCtD
Metoclopramide—Oedema—Travoprost—glaucoma	0.000462	0.00161	CcSEcCtD
Metoclopramide—Rash—Methazolamide—glaucoma	0.000462	0.0016	CcSEcCtD
Metoclopramide—Dermatitis—Methazolamide—glaucoma	0.000461	0.0016	CcSEcCtD
Metoclopramide—Nausea—Carbachol—glaucoma	0.000461	0.0016	CcSEcCtD
Metoclopramide—Headache—Methazolamide—glaucoma	0.000459	0.00159	CcSEcCtD
Metoclopramide—Anxiety—Pilocarpine—glaucoma	0.000456	0.00159	CcSEcCtD
Metoclopramide—Hypotension—Brimonidine—glaucoma	0.000454	0.00158	CcSEcCtD
Metoclopramide—Nausea—Levobunolol—glaucoma	0.000454	0.00158	CcSEcCtD
Metoclopramide—Tachycardia—Travoprost—glaucoma	0.000451	0.00157	CcSEcCtD
Metoclopramide—Somnolence—Acetazolamide—glaucoma	0.000451	0.00157	CcSEcCtD
Metoclopramide—Rash—Latanoprost—glaucoma	0.000447	0.00155	CcSEcCtD
Metoclopramide—Agranulocytosis—Betaxolol—glaucoma	0.000447	0.00155	CcSEcCtD
Metoclopramide—Dermatitis—Latanoprost—glaucoma	0.000446	0.00155	CcSEcCtD
Metoclopramide—Tachycardia—Brinzolamide—glaucoma	0.000446	0.00155	CcSEcCtD
Metoclopramide—Headache—Latanoprost—glaucoma	0.000444	0.00154	CcSEcCtD
Metoclopramide—Confusional state—Pilocarpine—glaucoma	0.000443	0.00154	CcSEcCtD
Metoclopramide—Insomnia—Brimonidine—glaucoma	0.00044	0.00153	CcSEcCtD
Metoclopramide—Oedema—Pilocarpine—glaucoma	0.000439	0.00153	CcSEcCtD
Metoclopramide—Asthma—Timolol—glaucoma	0.000438	0.00152	CcSEcCtD
Metoclopramide—Bradycardia—Betaxolol—glaucoma	0.000437	0.00152	CcSEcCtD
Metoclopramide—Fatigue—Acetazolamide—glaucoma	0.000437	0.00152	CcSEcCtD
Metoclopramide—Nausea—Methazolamide—glaucoma	0.000435	0.00151	CcSEcCtD
Metoclopramide—Hypotension—Dorzolamide—glaucoma	0.000434	0.00151	CcSEcCtD
Metoclopramide—Dyspnoea—Brimonidine—glaucoma	0.000434	0.00151	CcSEcCtD
Metoclopramide—Somnolence—Brimonidine—glaucoma	0.000432	0.0015	CcSEcCtD
Metoclopramide—Hypotension—Travoprost—glaucoma	0.000432	0.0015	CcSEcCtD
Metoclopramide—Bronchospasm—Timolol—glaucoma	0.000431	0.0015	CcSEcCtD
Metoclopramide—Tachycardia—Pilocarpine—glaucoma	0.000428	0.00149	CcSEcCtD
Metoclopramide—Hallucination—Betaxolol—glaucoma	0.000427	0.00149	CcSEcCtD
Metoclopramide—Hypotension—Brinzolamide—glaucoma	0.000427	0.00148	CcSEcCtD
Metoclopramide—Insomnia—Dorzolamide—glaucoma	0.00042	0.00146	CcSEcCtD
Metoclopramide—Fatigue—Brimonidine—glaucoma	0.000419	0.00146	CcSEcCtD
Metoclopramide—Feeling abnormal—Acetazolamide—glaucoma	0.000418	0.00145	CcSEcCtD
Metoclopramide—Hypersensitivity—Apraclonidine—glaucoma	0.000417	0.00145	CcSEcCtD
Metoclopramide—Nervousness—Clonidine—glaucoma	0.000417	0.00145	CcSEcCtD
Metoclopramide—Dyspnoea—Dorzolamide—glaucoma	0.000414	0.00144	CcSEcCtD
Metoclopramide—Visual impairment—Betaxolol—glaucoma	0.000414	0.00144	CcSEcCtD
Metoclopramide—Insomnia—Brinzolamide—glaucoma	0.000413	0.00144	CcSEcCtD
Metoclopramide—Somnolence—Dorzolamide—glaucoma	0.000413	0.00144	CcSEcCtD
Metoclopramide—Muscle spasms—Clonidine—glaucoma	0.000413	0.00144	CcSEcCtD
Metoclopramide—Dyspnoea—Travoprost—glaucoma	0.000412	0.00143	CcSEcCtD
Metoclopramide—Hypotension—Pilocarpine—glaucoma	0.00041	0.00143	CcSEcCtD
Metoclopramide—Dyspnoea—Brinzolamide—glaucoma	0.000407	0.00142	CcSEcCtD
Metoclopramide—Asthenia—Apraclonidine—glaucoma	0.000406	0.00141	CcSEcCtD
Metoclopramide—Somnolence—Brinzolamide—glaucoma	0.000406	0.00141	CcSEcCtD
Metoclopramide—Erectile dysfunction—Timolol—glaucoma	0.000404	0.0014	CcSEcCtD
Metoclopramide—Urticaria—Acetazolamide—glaucoma	0.000403	0.0014	CcSEcCtD
Metoclopramide—Tremor—Clonidine—glaucoma	0.000402	0.0014	CcSEcCtD
Metoclopramide—Body temperature increased—Acetazolamide—glaucoma	0.000401	0.00139	CcSEcCtD
Metoclopramide—Fatigue—Dorzolamide—glaucoma	0.0004	0.00139	CcSEcCtD
Metoclopramide—Fatigue—Travoprost—glaucoma	0.000399	0.00139	CcSEcCtD
Metoclopramide—Flushing—Betaxolol—glaucoma	0.000399	0.00139	CcSEcCtD
Metoclopramide—Insomnia—Pilocarpine—glaucoma	0.000397	0.00138	CcSEcCtD
Metoclopramide—Agitation—Clonidine—glaucoma	0.000395	0.00137	CcSEcCtD
Metoclopramide—Asthenia—Bimatoprost—glaucoma	0.000394	0.00137	CcSEcCtD
Metoclopramide—Fatigue—Brinzolamide—glaucoma	0.000394	0.00137	CcSEcCtD
Metoclopramide—Angioedema—Clonidine—glaucoma	0.000392	0.00136	CcSEcCtD
Metoclopramide—Dyspnoea—Pilocarpine—glaucoma	0.000391	0.00136	CcSEcCtD
Metoclopramide—Somnolence—Pilocarpine—glaucoma	0.00039	0.00136	CcSEcCtD
Metoclopramide—Depression—Timolol—glaucoma	0.00039	0.00136	CcSEcCtD
Metoclopramide—Diarrhoea—Apraclonidine—glaucoma	0.000388	0.00135	CcSEcCtD
Metoclopramide—Feeling abnormal—Dorzolamide—glaucoma	0.000383	0.00133	CcSEcCtD
Metoclopramide—Feeling abnormal—Travoprost—glaucoma	0.000381	0.00133	CcSEcCtD
Metoclopramide—Palpitations—Clonidine—glaucoma	0.00038	0.00132	CcSEcCtD
Metoclopramide—Feeling abnormal—Brinzolamide—glaucoma	0.000376	0.00131	CcSEcCtD
Metoclopramide—Dizziness—Apraclonidine—glaucoma	0.000375	0.0013	CcSEcCtD
Metoclopramide—Urticaria—Dorzolamide—glaucoma	0.000369	0.00128	CcSEcCtD
Metoclopramide—Body temperature increased—Dorzolamide—glaucoma	0.000367	0.00128	CcSEcCtD
Metoclopramide—Agranulocytosis—Timolol—glaucoma	0.000365	0.00127	CcSEcCtD
Metoclopramide—Anxiety—Clonidine—glaucoma	0.000364	0.00127	CcSEcCtD
Metoclopramide—Asthenia—Acetazolamide—glaucoma	0.000364	0.00126	CcSEcCtD
Metoclopramide—Dizziness—Bimatoprost—glaucoma	0.000363	0.00126	CcSEcCtD
Metoclopramide—Nervousness—Betaxolol—glaucoma	0.000363	0.00126	CcSEcCtD
Metoclopramide—Urticaria—Brinzolamide—glaucoma	0.000363	0.00126	CcSEcCtD
Metoclopramide—Feeling abnormal—Pilocarpine—glaucoma	0.000362	0.00126	CcSEcCtD
Metoclopramide—Muscle spasms—Betaxolol—glaucoma	0.000359	0.00125	CcSEcCtD
Metoclopramide—Hypersensitivity—Brimonidine—glaucoma	0.000358	0.00125	CcSEcCtD
Metoclopramide—Bradycardia—Timolol—glaucoma	0.000357	0.00124	CcSEcCtD
Metoclopramide—Dermatitis—Apraclonidine—glaucoma	0.000357	0.00124	CcSEcCtD
Metoclopramide—Headache—Apraclonidine—glaucoma	0.000355	0.00123	CcSEcCtD
Metoclopramide—Confusional state—Clonidine—glaucoma	0.000353	0.00123	CcSEcCtD
Metoclopramide—Oedema—Clonidine—glaucoma	0.000351	0.00122	CcSEcCtD
Metoclopramide—Tremor—Betaxolol—glaucoma	0.00035	0.00122	CcSEcCtD
Metoclopramide—Hallucination—Timolol—glaucoma	0.000349	0.00121	CcSEcCtD
Metoclopramide—Asthenia—Brimonidine—glaucoma	0.000349	0.00121	CcSEcCtD
Metoclopramide—Body temperature increased—Pilocarpine—glaucoma	0.000347	0.00121	CcSEcCtD
Metoclopramide—Diarrhoea—Acetazolamide—glaucoma	0.000347	0.00121	CcSEcCtD
Metoclopramide—Rash—Bimatoprost—glaucoma	0.000346	0.0012	CcSEcCtD
Metoclopramide—Dermatitis—Bimatoprost—glaucoma	0.000346	0.0012	CcSEcCtD
Metoclopramide—Headache—Bimatoprost—glaucoma	0.000344	0.0012	CcSEcCtD
Metoclopramide—Hypersensitivity—Dorzolamide—glaucoma	0.000342	0.00119	CcSEcCtD
Metoclopramide—Tachycardia—Clonidine—glaucoma	0.000342	0.00119	CcSEcCtD
Metoclopramide—Hypersensitivity—Travoprost—glaucoma	0.000341	0.00118	CcSEcCtD
Metoclopramide—Visual impairment—Timolol—glaucoma	0.000338	0.00118	CcSEcCtD
Metoclopramide—Nausea—Apraclonidine—glaucoma	0.000337	0.00117	CcSEcCtD
Metoclopramide—Hypersensitivity—Brinzolamide—glaucoma	0.000336	0.00117	CcSEcCtD
Metoclopramide—Dizziness—Acetazolamide—glaucoma	0.000335	0.00117	CcSEcCtD
Metoclopramide—Asthenia—Dorzolamide—glaucoma	0.000333	0.00116	CcSEcCtD
Metoclopramide—Asthenia—Travoprost—glaucoma	0.000332	0.00115	CcSEcCtD
Metoclopramide—Palpitations—Betaxolol—glaucoma	0.00033	0.00115	CcSEcCtD
Metoclopramide—Asthenia—Brinzolamide—glaucoma	0.000328	0.00114	CcSEcCtD
Metoclopramide—Hypotension—Clonidine—glaucoma	0.000328	0.00114	CcSEcCtD
Metoclopramide—Nausea—Bimatoprost—glaucoma	0.000326	0.00113	CcSEcCtD
Metoclopramide—Hypersensitivity—Pilocarpine—glaucoma	0.000323	0.00112	CcSEcCtD
Metoclopramide—Dizziness—Brimonidine—glaucoma	0.000322	0.00112	CcSEcCtD
Metoclopramide—Diarrhoea—Dorzolamide—glaucoma	0.000318	0.00111	CcSEcCtD
Metoclopramide—Headache—Acetazolamide—glaucoma	0.000317	0.0011	CcSEcCtD
Metoclopramide—Anxiety—Betaxolol—glaucoma	0.000317	0.0011	CcSEcCtD
Metoclopramide—Insomnia—Clonidine—glaucoma	0.000317	0.0011	CcSEcCtD
Metoclopramide—Diarrhoea—Travoprost—glaucoma	0.000316	0.0011	CcSEcCtD
Metoclopramide—Asthenia—Pilocarpine—glaucoma	0.000315	0.00109	CcSEcCtD
Metoclopramide—Dyspnoea—Clonidine—glaucoma	0.000312	0.00109	CcSEcCtD
Metoclopramide—Diarrhoea—Brinzolamide—glaucoma	0.000312	0.00109	CcSEcCtD
Metoclopramide—Somnolence—Clonidine—glaucoma	0.000312	0.00108	CcSEcCtD
Metoclopramide—Confusional state—Betaxolol—glaucoma	0.000308	0.00107	CcSEcCtD
Metoclopramide—Dizziness—Dorzolamide—glaucoma	0.000307	0.00107	CcSEcCtD
Metoclopramide—Rash—Brimonidine—glaucoma	0.000307	0.00107	CcSEcCtD
Metoclopramide—Dermatitis—Brimonidine—glaucoma	0.000306	0.00107	CcSEcCtD
Metoclopramide—Dizziness—Travoprost—glaucoma	0.000306	0.00106	CcSEcCtD
Metoclopramide—Oedema—Betaxolol—glaucoma	0.000305	0.00106	CcSEcCtD
Metoclopramide—Headache—Brimonidine—glaucoma	0.000305	0.00106	CcSEcCtD
Metoclopramide—Fatigue—Clonidine—glaucoma	0.000302	0.00105	CcSEcCtD
Metoclopramide—Dizziness—Brinzolamide—glaucoma	0.000302	0.00105	CcSEcCtD
Metoclopramide—Nausea—Acetazolamide—glaucoma	0.000301	0.00105	CcSEcCtD
Metoclopramide—Diarrhoea—Pilocarpine—glaucoma	0.0003	0.00104	CcSEcCtD
Metoclopramide—Tachycardia—Betaxolol—glaucoma	0.000298	0.00104	CcSEcCtD
Metoclopramide—Nervousness—Timolol—glaucoma	0.000297	0.00103	CcSEcCtD
Metoclopramide—Rash—Dorzolamide—glaucoma	0.000293	0.00102	CcSEcCtD
Metoclopramide—Dermatitis—Dorzolamide—glaucoma	0.000293	0.00102	CcSEcCtD
Metoclopramide—Rash—Travoprost—glaucoma	0.000292	0.00101	CcSEcCtD
Metoclopramide—Dermatitis—Travoprost—glaucoma	0.000291	0.00101	CcSEcCtD
Metoclopramide—Headache—Dorzolamide—glaucoma	0.000291	0.00101	CcSEcCtD
Metoclopramide—Dizziness—Pilocarpine—glaucoma	0.00029	0.00101	CcSEcCtD
Metoclopramide—Headache—Travoprost—glaucoma	0.00029	0.00101	CcSEcCtD
Metoclopramide—Nausea—Brimonidine—glaucoma	0.000289	0.001	CcSEcCtD
Metoclopramide—Feeling abnormal—Clonidine—glaucoma	0.000289	0.001	CcSEcCtD
Metoclopramide—Rash—Brinzolamide—glaucoma	0.000288	0.001	CcSEcCtD
Metoclopramide—Dermatitis—Brinzolamide—glaucoma	0.000288	0.001	CcSEcCtD
Metoclopramide—Headache—Brinzolamide—glaucoma	0.000286	0.000995	CcSEcCtD
Metoclopramide—Hypotension—Betaxolol—glaucoma	0.000285	0.000991	CcSEcCtD
Metoclopramide—Angioedema—Timolol—glaucoma	0.000279	0.00097	CcSEcCtD
Metoclopramide—Urticaria—Clonidine—glaucoma	0.000278	0.000968	CcSEcCtD
Metoclopramide—Body temperature increased—Clonidine—glaucoma	0.000277	0.000963	CcSEcCtD
Metoclopramide—Rash—Pilocarpine—glaucoma	0.000277	0.000962	CcSEcCtD
Metoclopramide—Dermatitis—Pilocarpine—glaucoma	0.000276	0.000961	CcSEcCtD
Metoclopramide—Insomnia—Betaxolol—glaucoma	0.000276	0.00096	CcSEcCtD
Metoclopramide—Nausea—Dorzolamide—glaucoma	0.000276	0.000959	CcSEcCtD
Metoclopramide—Headache—Pilocarpine—glaucoma	0.000275	0.000956	CcSEcCtD
Metoclopramide—Nausea—Travoprost—glaucoma	0.000275	0.000955	CcSEcCtD
Metoclopramide—Dyspnoea—Betaxolol—glaucoma	0.000272	0.000946	CcSEcCtD
Metoclopramide—Nausea—Brinzolamide—glaucoma	0.000271	0.000943	CcSEcCtD
Metoclopramide—Palpitations—Timolol—glaucoma	0.00027	0.000939	CcSEcCtD
Metoclopramide—Hypertension—Timolol—glaucoma	0.000264	0.000917	CcSEcCtD
Metoclopramide—Fatigue—Betaxolol—glaucoma	0.000263	0.000915	CcSEcCtD
Metoclopramide—Nausea—Pilocarpine—glaucoma	0.000261	0.000906	CcSEcCtD
Metoclopramide—Anxiety—Timolol—glaucoma	0.000259	0.000901	CcSEcCtD
Metoclopramide—Hypersensitivity—Clonidine—glaucoma	0.000258	0.000898	CcSEcCtD
Metoclopramide—Asthenia—Clonidine—glaucoma	0.000251	0.000874	CcSEcCtD
Metoclopramide—Feeling abnormal—Betaxolol—glaucoma	0.000251	0.000874	CcSEcCtD
Metoclopramide—Confusional state—Timolol—glaucoma	0.000251	0.000874	CcSEcCtD
Metoclopramide—Oedema—Timolol—glaucoma	0.000249	0.000867	CcSEcCtD
Metoclopramide—Urticaria—Betaxolol—glaucoma	0.000242	0.000843	CcSEcCtD
Metoclopramide—Body temperature increased—Betaxolol—glaucoma	0.000241	0.000839	CcSEcCtD
Metoclopramide—Diarrhoea—Clonidine—glaucoma	0.00024	0.000834	CcSEcCtD
Metoclopramide—CYP2D6—Melatonin metabolism and effects—APOE—glaucoma	0.000235	0.00293	CbGpPWpGaD
Metoclopramide—Hypotension—Timolol—glaucoma	0.000233	0.00081	CcSEcCtD
Metoclopramide—Dizziness—Clonidine—glaucoma	0.000232	0.000806	CcSEcCtD
Metoclopramide—HTR4—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000231	0.00288	CbGpPWpGaD
Metoclopramide—Insomnia—Timolol—glaucoma	0.000225	0.000784	CcSEcCtD
Metoclopramide—Hypersensitivity—Betaxolol—glaucoma	0.000225	0.000782	CcSEcCtD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000223	0.00277	CbGpPWpGaD
Metoclopramide—Dyspnoea—Timolol—glaucoma	0.000222	0.000773	CcSEcCtD
Metoclopramide—Somnolence—Timolol—glaucoma	0.000222	0.000771	CcSEcCtD
Metoclopramide—DRD3—GPCR ligand binding—PTGFR—glaucoma	0.000222	0.00275	CbGpPWpGaD
Metoclopramide—Rash—Clonidine—glaucoma	0.000221	0.000768	CcSEcCtD
Metoclopramide—Dermatitis—Clonidine—glaucoma	0.000221	0.000768	CcSEcCtD
Metoclopramide—Headache—Clonidine—glaucoma	0.00022	0.000763	CcSEcCtD
Metoclopramide—Asthenia—Betaxolol—glaucoma	0.000219	0.000761	CcSEcCtD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000218	0.00271	CbGpPWpGaD
Metoclopramide—Fatigue—Timolol—glaucoma	0.000215	0.000747	CcSEcCtD
Metoclopramide—Diarrhoea—Betaxolol—glaucoma	0.000209	0.000726	CcSEcCtD
Metoclopramide—Nausea—Clonidine—glaucoma	0.000208	0.000724	CcSEcCtD
Metoclopramide—Feeling abnormal—Timolol—glaucoma	0.000205	0.000714	CcSEcCtD
Metoclopramide—HTR4—Signaling Pathways—OPN4—glaucoma	0.000204	0.00254	CbGpPWpGaD
Metoclopramide—HTR3A—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000204	0.00253	CbGpPWpGaD
Metoclopramide—Dizziness—Betaxolol—glaucoma	0.000202	0.000702	CcSEcCtD
Metoclopramide—HTR4—GPCR ligand binding—EDN1—glaucoma	0.000202	0.00251	CbGpPWpGaD
Metoclopramide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.0002	0.00249	CbGpPWpGaD
Metoclopramide—Urticaria—Timolol—glaucoma	0.000198	0.000689	CcSEcCtD
Metoclopramide—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000197	0.00245	CbGpPWpGaD
Metoclopramide—Body temperature increased—Timolol—glaucoma	0.000197	0.000685	CcSEcCtD
Metoclopramide—Rash—Betaxolol—glaucoma	0.000192	0.000669	CcSEcCtD
Metoclopramide—Dermatitis—Betaxolol—glaucoma	0.000192	0.000668	CcSEcCtD
Metoclopramide—Headache—Betaxolol—glaucoma	0.000191	0.000665	CcSEcCtD
Metoclopramide—HTR4—Signaling Pathways—HEYL—glaucoma	0.00019	0.00236	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—OPN4—glaucoma	0.000188	0.00234	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—OPN4—glaucoma	0.000184	0.00229	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—PTGFR—glaucoma	0.000184	0.00229	CbGpPWpGaD
Metoclopramide—Hypersensitivity—Timolol—glaucoma	0.000184	0.000639	CcSEcCtD
Metoclopramide—Nausea—Betaxolol—glaucoma	0.000181	0.00063	CcSEcCtD
Metoclopramide—Asthenia—Timolol—glaucoma	0.000179	0.000622	CcSEcCtD
Metoclopramide—HTR4—GPCR ligand binding—C3—glaucoma	0.000176	0.00219	CbGpPWpGaD
Metoclopramide—Diarrhoea—Timolol—glaucoma	0.000171	0.000593	CcSEcCtD
Metoclopramide—CYP11B2—Metabolism—CA1—glaucoma	0.00017	0.00211	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—PTGFR—glaucoma	0.00017	0.00211	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—PTGFR—glaucoma	0.000166	0.00206	CbGpPWpGaD
Metoclopramide—Dizziness—Timolol—glaucoma	0.000165	0.000573	CcSEcCtD
Metoclopramide—CYP11B2—Metabolism—CTSA—glaucoma	0.000164	0.00204	CbGpPWpGaD
Metoclopramide—DRD3—Circadian rythm related genes—NGFR—glaucoma	0.000164	0.00204	CbGpPWpGaD
Metoclopramide—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000162	0.00202	CbGpPWpGaD
Metoclopramide—Rash—Timolol—glaucoma	0.000157	0.000547	CcSEcCtD
Metoclopramide—Dermatitis—Timolol—glaucoma	0.000157	0.000546	CcSEcCtD
Metoclopramide—HTR4—Signaling by GPCR—SMO—glaucoma	0.000157	0.00195	CbGpPWpGaD
Metoclopramide—Headache—Timolol—glaucoma	0.000156	0.000543	CcSEcCtD
Metoclopramide—DRD3—Circadian rythm related genes—NTRK1—glaucoma	0.000156	0.00194	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—CA2—glaucoma	0.000155	0.00193	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000152	0.00189	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000152	0.00189	CbGpPWpGaD
Metoclopramide—HTR3A—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000149	0.00185	CbGpPWpGaD
Metoclopramide—Nausea—Timolol—glaucoma	0.000148	0.000515	CcSEcCtD
Metoclopramide—CYP11B1—Metabolism—CA1—glaucoma	0.000146	0.00182	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—RPTOR—glaucoma	0.000144	0.00179	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—CTSA—glaucoma	0.000142	0.00176	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—NCK2—glaucoma	0.000139	0.00173	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—OPN4—glaucoma	0.000139	0.00173	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—CA1—glaucoma	0.000137	0.0017	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—CA2—glaucoma	0.000134	0.00166	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—CTSA—glaucoma	0.000133	0.00165	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000131	0.00163	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000131	0.00163	CbGpPWpGaD
Metoclopramide—HTR3A—SIDS Susceptibility Pathways—TNF—glaucoma	0.000127	0.00158	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—OPN4—glaucoma	0.000126	0.00157	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—NGFR—glaucoma	0.000126	0.00156	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—PTGFR—glaucoma	0.000125	0.00156	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—CA2—glaucoma	0.000125	0.00156	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—NGFR—glaucoma	0.000123	0.00153	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000122	0.00152	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000122	0.00152	CbGpPWpGaD
Metoclopramide—DRD3—Circadian rythm related genes—FAS—glaucoma	0.000122	0.00152	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—NTRK1—glaucoma	0.000119	0.00148	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—HDAC9—glaucoma	0.000119	0.00147	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—NTRK1—glaucoma	0.000117	0.00145	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—EDN1—glaucoma	0.000114	0.00142	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—PTGFR—glaucoma	0.000114	0.00141	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—SMO—glaucoma	0.000112	0.00139	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—TXN—glaucoma	0.000109	0.00136	CbGpPWpGaD
Metoclopramide—CHRM1—G alpha (q) signalling events—EDN1—glaucoma	0.000109	0.00136	CbGpPWpGaD
Metoclopramide—CYP2D6—Biological oxidations—GSTT1—glaucoma	0.000108	0.00134	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—LRP12—glaucoma	0.000108	0.00134	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—OPN4—glaucoma	0.000106	0.00132	CbGpPWpGaD
Metoclopramide—DRD3—G alpha (i) signalling events—C3—glaucoma	0.000106	0.00132	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—OPN4—glaucoma	0.000104	0.00129	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—EDN1—glaucoma	0.000104	0.00129	CbGpPWpGaD
Metoclopramide—CHRM1—Regulation of Actin Cytoskeleton—FN1—glaucoma	0.000101	0.00125	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism of lipids and lipoproteins—APOE—glaucoma	9.99e-05	0.00124	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—C3—glaucoma	9.96e-05	0.00124	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.89e-05	0.00123	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	9.78e-05	0.00122	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	9.67e-05	0.0012	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—OPN4—glaucoma	9.66e-05	0.0012	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—PTGFR—glaucoma	9.58e-05	0.00119	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—OPN4—glaucoma	9.46e-05	0.00118	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—TXN—glaucoma	9.43e-05	0.00117	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—PTGFR—glaucoma	9.38e-05	0.00117	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—FAS—glaucoma	9.35e-05	0.00116	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—SMO—glaucoma	9.27e-05	0.00115	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—FAS—glaucoma	9.15e-05	0.00114	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—C3—glaucoma	9.04e-05	0.00112	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—TXN—glaucoma	8.82e-05	0.0011	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—PTGFR—glaucoma	8.7e-05	0.00108	CbGpPWpGaD
Metoclopramide—CYP2D6—Biological oxidations—CYP1B1—glaucoma	8.62e-05	0.00107	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—APOE—glaucoma	8.61e-05	0.00107	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—SMO—glaucoma	8.55e-05	0.00106	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	8.53e-05	0.00106	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—PTGFR—glaucoma	8.51e-05	0.00106	CbGpPWpGaD
Metoclopramide—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	8.5e-05	0.00106	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—GSTT1—glaucoma	8.49e-05	0.00105	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—NTRK2—glaucoma	8.48e-05	0.00105	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	8.45e-05	0.00105	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—SMO—glaucoma	8.37e-05	0.00104	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—LRP12—glaucoma	8.23e-05	0.00102	CbGpPWpGaD
Metoclopramide—DRD2—G alpha (i) signalling events—C3—glaucoma	8.13e-05	0.00101	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—LRP12—glaucoma	8.06e-05	0.001	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	8.05e-05	0.001	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	7.97e-05	0.000991	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CA5A—glaucoma	7.58e-05	0.000942	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—NARFL—glaucoma	7.58e-05	0.000942	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—OPN4—glaucoma	7.46e-05	0.000927	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	7.4e-05	0.00092	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—EDN1—glaucoma	7.37e-05	0.000916	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—GSTT1—glaucoma	7.31e-05	0.000909	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—NGFR—glaucoma	7.28e-05	0.000905	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	7.24e-05	0.0009	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HEYL—glaucoma	6.93e-05	0.000862	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—NTRK1—glaucoma	6.91e-05	0.00086	CbGpPWpGaD
Metoclopramide—CYP2D6—Biological oxidations—GSTM1—glaucoma	6.89e-05	0.000856	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.84e-05	0.00085	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—GSTT1—glaucoma	6.84e-05	0.00085	CbGpPWpGaD
Metoclopramide—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	6.79e-05	0.000845	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—CYP1B1—glaucoma	6.76e-05	0.00084	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—ABCA1—glaucoma	6.76e-05	0.00084	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PTGFR—glaucoma	6.72e-05	0.000835	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	6.47e-05	0.000804	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—C3—glaucoma	6.43e-05	0.0008	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CDKN2B—glaucoma	6.37e-05	0.000792	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	6.33e-05	0.000787	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—EDN1—glaucoma	6.11e-05	0.00076	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.9e-05	0.000733	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—ABCA1—glaucoma	5.83e-05	0.000724	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—CYP1B1—glaucoma	5.83e-05	0.000724	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—SMO—glaucoma	5.73e-05	0.000713	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—OPN4—glaucoma	5.71e-05	0.00071	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—EDN1—glaucoma	5.64e-05	0.000701	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—NGF—glaucoma	5.62e-05	0.000698	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—OPN4—glaucoma	5.59e-05	0.000694	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—EDN1—glaucoma	5.52e-05	0.000686	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.52e-05	0.000686	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—ABCA1—glaucoma	5.45e-05	0.000677	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—CYP1B1—glaucoma	5.45e-05	0.000677	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—GSTM1—glaucoma	5.4e-05	0.000672	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—C3—glaucoma	5.34e-05	0.000664	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HEYL—glaucoma	5.31e-05	0.00066	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—RPTOR—glaucoma	5.26e-05	0.000653	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HEYL—glaucoma	5.19e-05	0.000646	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PTGFR—glaucoma	5.14e-05	0.000639	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NCK2—glaucoma	5.09e-05	0.000633	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PTGFR—glaucoma	5.03e-05	0.000625	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—APOE—glaucoma	4.97e-05	0.000618	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CAV1—glaucoma	4.93e-05	0.000612	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—C3—glaucoma	4.92e-05	0.000612	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—C3—glaucoma	4.82e-05	0.000599	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—MTHFR—glaucoma	4.78e-05	0.000594	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—FN1—glaucoma	4.69e-05	0.000583	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—GSTM1—glaucoma	4.66e-05	0.000579	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—BAD—glaucoma	4.63e-05	0.000576	CbGpPWpGaD
Metoclopramide—DRD3—Circadian rythm related genes—TP53—glaucoma	4.57e-05	0.000568	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—APOE—glaucoma	4.45e-05	0.000553	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—CAV1—glaucoma	4.41e-05	0.000548	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—SMO—glaucoma	4.39e-05	0.000545	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—GSTM1—glaucoma	4.36e-05	0.000542	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HDAC9—glaucoma	4.33e-05	0.000538	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—SMO—glaucoma	4.29e-05	0.000534	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—EDN1—glaucoma	4.16e-05	0.000517	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—MTHFR—glaucoma	4.12e-05	0.000512	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—RPTOR—glaucoma	4.02e-05	0.0005	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—RPTOR—glaucoma	3.94e-05	0.000489	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NCK2—glaucoma	3.89e-05	0.000484	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—MTHFR—glaucoma	3.85e-05	0.000479	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—APOE—glaucoma	3.83e-05	0.000476	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NCK2—glaucoma	3.81e-05	0.000474	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—CAV1—glaucoma	3.8e-05	0.000472	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—EDN1—glaucoma	3.78e-05	0.00047	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—NOS3—glaucoma	3.73e-05	0.000463	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CA1—glaucoma	3.7e-05	0.00046	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—C3—glaucoma	3.64e-05	0.000452	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CTSA—glaucoma	3.59e-05	0.000446	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—APOE—glaucoma	3.58e-05	0.000446	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—CAV1—glaucoma	3.55e-05	0.000441	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—TP53—glaucoma	3.5e-05	0.000435	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—TP53—glaucoma	3.42e-05	0.000426	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—SMO—glaucoma	3.39e-05	0.000421	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CA2—glaucoma	3.39e-05	0.000421	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—NOS3—glaucoma	3.33e-05	0.000414	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HDAC9—glaucoma	3.31e-05	0.000412	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—C3—glaucoma	3.3e-05	0.00041	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HDAC9—glaucoma	3.24e-05	0.000403	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CDKN1B—glaucoma	3.23e-05	0.000401	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—EDN1—glaucoma	3.18e-05	0.000396	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—EDN1—glaucoma	3.12e-05	0.000387	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NTRK2—glaucoma	3.1e-05	0.000385	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—PTGS2—glaucoma	3.05e-05	0.000379	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—MMP9—glaucoma	2.99e-05	0.000372	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—EDN1—glaucoma	2.89e-05	0.00036	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—NOS3—glaucoma	2.87e-05	0.000357	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—EDN1—glaucoma	2.83e-05	0.000352	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—C3—glaucoma	2.78e-05	0.000346	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—C3—glaucoma	2.72e-05	0.000338	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—NOS3—glaucoma	2.69e-05	0.000334	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—VEGFA—glaucoma	2.68e-05	0.000334	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NGFR—glaucoma	2.66e-05	0.00033	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—PTGS2—glaucoma	2.63e-05	0.000326	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—SMO—glaucoma	2.59e-05	0.000322	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—SMO—glaucoma	2.54e-05	0.000315	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—C3—glaucoma	2.53e-05	0.000314	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NTRK1—glaucoma	2.53e-05	0.000314	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—C3—glaucoma	2.47e-05	0.000307	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—PTGS2—glaucoma	2.46e-05	0.000305	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—TXN—glaucoma	2.39e-05	0.000297	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NTRK2—glaucoma	2.37e-05	0.000295	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CDKN2B—glaucoma	2.33e-05	0.000289	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NTRK2—glaucoma	2.32e-05	0.000288	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—EDN1—glaucoma	2.23e-05	0.000278	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NGF—glaucoma	2.05e-05	0.000255	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NGFR—glaucoma	2.03e-05	0.000253	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—TP53—glaucoma	2.03e-05	0.000252	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NGFR—glaucoma	1.99e-05	0.000247	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—C3—glaucoma	1.95e-05	0.000242	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NTRK1—glaucoma	1.93e-05	0.00024	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NTRK1—glaucoma	1.89e-05	0.000235	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GSTT1—glaucoma	1.85e-05	0.00023	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—APOE—glaucoma	1.82e-05	0.000226	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CAV1—glaucoma	1.8e-05	0.000224	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CDKN2B—glaucoma	1.78e-05	0.000221	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CDKN2B—glaucoma	1.74e-05	0.000217	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—FN1—glaucoma	1.71e-05	0.000213	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—EDN1—glaucoma	1.71e-05	0.000212	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—BAD—glaucoma	1.69e-05	0.00021	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—EDN1—glaucoma	1.67e-05	0.000208	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NGF—glaucoma	1.57e-05	0.000195	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NGF—glaucoma	1.54e-05	0.000191	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—C3—glaucoma	1.49e-05	0.000186	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ABCA1—glaucoma	1.47e-05	0.000183	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CYP1B1—glaucoma	1.47e-05	0.000183	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—C3—glaucoma	1.46e-05	0.000182	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—APOE—glaucoma	1.39e-05	0.000173	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CAV1—glaucoma	1.38e-05	0.000171	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NOS3—glaucoma	1.36e-05	0.000169	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—APOE—glaucoma	1.36e-05	0.000169	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CAV1—glaucoma	1.35e-05	0.000167	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—FN1—glaucoma	1.31e-05	0.000163	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—BAD—glaucoma	1.29e-05	0.000161	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—FN1—glaucoma	1.28e-05	0.000159	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—BAD—glaucoma	1.27e-05	0.000158	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CDKN1B—glaucoma	1.18e-05	0.000146	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GSTM1—glaucoma	1.18e-05	0.000146	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MMP9—glaucoma	1.09e-05	0.000136	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—MTHFR—glaucoma	1.04e-05	0.000129	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NOS3—glaucoma	1.04e-05	0.000129	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NOS3—glaucoma	1.02e-05	0.000127	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—VEGFA—glaucoma	9.8e-06	0.000122	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—APOE—glaucoma	9.69e-06	0.00012	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CAV1—glaucoma	9.6e-06	0.000119	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CDKN1B—glaucoma	9.02e-06	0.000112	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CDKN1B—glaucoma	8.83e-06	0.00011	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MMP9—glaucoma	8.35e-06	0.000104	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MMP9—glaucoma	8.17e-06	0.000102	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—VEGFA—glaucoma	7.5e-06	9.32e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TP53—glaucoma	7.41e-06	9.21e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—VEGFA—glaucoma	7.34e-06	9.12e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—NOS3—glaucoma	7.26e-06	9.03e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PTGS2—glaucoma	6.64e-06	8.26e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TP53—glaucoma	5.67e-06	7.04e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TP53—glaucoma	5.55e-06	6.89e-05	CbGpPWpGaD
